- Home
- TCRX vs CGO Comparison
TCRX vs CGO Comparison
Compare TCRX & CGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRX
- CGO
- Stock Information
- Founded
- TCRX 2018
- CGO 2004
- Country
- TCRX United States
- CGO United States
- Employees
- TCRX N/A
- CGO N/A
- Industry
- TCRX Biotechnology: Pharmaceutical Preparations
- CGO Investment Managers
- Sector
- TCRX Health Care
- CGO Finance
- Exchange
- TCRX Nasdaq
- CGO Nasdaq
- Market Cap
- TCRX 115.8M
- CGO 111.7M
- IPO Year
- TCRX 2021
- CGO N/A
- Fundamental
- Price
- TCRX $2.17
- CGO $11.52
- Analyst Decision
- TCRX Strong Buy
- CGO
- Analyst Count
- TCRX 5
- CGO 0
- Target Price
- TCRX $11.40
- CGO N/A
- AVG Volume (30 Days)
- TCRX 382.5K
- CGO 34.7K
- Earning Date
- TCRX 03-05-2025
- CGO 01-01-0001
- Dividend Yield
- TCRX N/A
- CGO 9.25%
- EPS Growth
- TCRX N/A
- CGO N/A
- EPS
- TCRX N/A
- CGO N/A
- Revenue
- TCRX $9,362,000.00
- CGO N/A
- Revenue This Year
- TCRX N/A
- CGO N/A
- Revenue Next Year
- TCRX $5.14
- CGO N/A
- P/E Ratio
- TCRX N/A
- CGO N/A
- Revenue Growth
- TCRX N/A
- CGO N/A
- 52 Week Low
- TCRX $1.99
- CGO $7.90
- 52 Week High
- TCRX $9.69
- CGO $10.93
- Technical
- Relative Strength Index (RSI)
- TCRX 37.12
- CGO 50.62
- Support Level
- TCRX $2.02
- CGO $11.41
- Resistance Level
- TCRX $2.17
- CGO $11.71
- Average True Range (ATR)
- TCRX 0.16
- CGO 0.18
- MACD
- TCRX 0.02
- CGO 0.01
- Stochastic Oscillator
- TCRX 26.47
- CGO 60.00
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About CGO Calamos Global Total Return Fund
Calamos Global Total Return Fund is a closed-end management investment company. The fund's investment objective is to provide total return through a combination of capital appreciation and current income. The fund invests in global equities, convertible securities, and high-yield corporate bonds.